Initially recognized for its involvement in immune surveillance through cytotoxic lymphocyte-mediated apoptosis, GzmB has extended its influence into several realms, including autoimmune diseases, inflammatory disorders, neurological disorders, cancer immunotherapies, and allogeneic hematopoietic cell transplantation. This evidence concerns the gene GZMB and nervous system disorder.